BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 11, 2011
View Archived Issues
Sanofi discloses novel agents for diabetic foot ulcers
Read More
Novel Novartis product enters phase I/II trial in healthy subjects and patients with diabetes
Read More
Roche discovers new phosphodiesterase 10A inhibitors
Read More
New histone deacetylase 9 inhibitors claimed
Read More
Novel B-raf inhibitors patented by Selexagen
Read More
NCCU patents new beta-nerve growth factor enhancers
Read More
FDA clears Newron to conduct first-in-human study of add-on therapy for schizophrenia
Read More
U.S. Department of Defense funds development of NeoStem stem cell technology for osteoporosis
Read More
New urine-based biomarker test predicts risk of prostate cancer in men with elevated PSA
Read More
GSK submits sNDA in U.S. for use of Horizant
Read More
Pluristem's agreement with United Therapeutics for PLX cells is effective
Read More
Amarin reaches SPA agreement with FDA for phase III REDUCE-IT trial
Read More
Array BioPharma and Genentech enter agreement for Chk1 program
Read More
NCI to sponsor clinical trials of Pharmacyclics BTK inhibitor
Read More
Ironwood Pharmaceuticals and Forest Laboratories submit linaclotide NDA for two indications
Read More
Novel injectable coacervate induces angiogenesis in vivo
Read More
Enobia raises funds for development of ENB-0040
Read More
Chugai files application for additional indication for Kytril in Japan
Read More
ThromboGenics expects ocriplasmin filings in U.S. and E.U. before year-end
Read More
Adventrx receives FDA complete response letter for Exelbine
Read More
New phase I trial of anticancer drug TKM-PLK1 cleared by FDA
Read More
Glenmark Pharmaceuticals initiates global phase IIb trials of revamilast
Read More
GWAS identifies new lung cancer susceptibility loci in Chinese population
Read More